Retatrutide Injections *Starter* Complete Kit
Retatrutide is an investigational injectable medication for obesity, type 2 diabetes, and metabolic diseases, targeting three metabolic pathways simultaneously.
- The description claims Retatrutide produces substantial weight loss, with up to 24% body weight reduction in Phase 2 trials and an average of 29% in Phase 3 trials.
- The description claims Retatrutide activates GLP-1, GIP, and glucagon receptors.
Specifications
- Select Month:
- One Month (5mg)
AI Readiness
Good foundation, but some important product data is still missing.
78%